Clinical Trials Directory

Trials / Completed

CompletedNCT01320137

Study in Allergic Adults to Support the Development of Immunological Assays

A Study in Adult Subjects With Allergy to Support the Development of Immunological Assays

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to develop and characterize immunological assays on blood samples.

Detailed description

This is a clinical study in which there is no vaccine administered. It is designed for research purposes such as developing immunological assays.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood withdrawalBlood sampling

Timeline

Start date
2011-03-31
Primary completion
2011-05-11
Completion
2011-05-11
First posted
2011-03-22
Last updated
2017-06-20
Results posted
2017-01-31

Locations

2 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01320137. Inclusion in this directory is not an endorsement.

Study in Allergic Adults to Support the Development of Immunological Assays (NCT01320137) · Clinical Trials Directory